Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 236,794,578 papers from all fields of science
Search
Sign In
Create Free Account
Xenical
Known as:
Hoffmann-La Roche brand of orlistat
, Roche brand of orlistat
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (1)
orlistat
orlistat 120 MG Oral Capsule [Xenical]
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Орлистат в комплексной терапии ожирения и сахарного диабета 2-го типа
А. М. Мкртумян
,
Е. В. Бирюкова
2017
Corpus ID: 80051765
Over the past years, the focus has been growing on the prevention and treatment of obesity. Obesity has long been considered not…
Expand
2014
2014
Integrated approach in the treatment of metabolic syndrome
V. Uchamprina
,
T. Romantsova
,
M. Kalashnikova
2014
Corpus ID: 70431874
The Goal of this study was to investigate the efficacy of the integrated approach for the treatment of metabolic syndrome (MS…
Expand
2011
2011
Trade secrets in balance as agencies issue new transparency rules
G. Sinha
Nature Biotechnology
2011
Corpus ID: 205265709
2010
2010
Amylin's $1 billion heavyweight deal
Hayley Birch
Nature Biotechnology
2010
Corpus ID: 8018524
2010
2010
Bariatrische Chirurgie und Schwangerschaft
B. Schultes
,
B. Ernst
,
M. Thurnheer
2010
Corpus ID: 79732997
Übergewicht und Adipositas ist weltweit eines der am stärksten zunehmenden gesundheitlichen Probleme. Bekanntermassen erhöht…
Expand
2008
2008
Does generic substitution always make sense?
P. Greenberg
Journal of Medical Economics
2008
Corpus ID: 8653161
Over the past 25 years, as healthcare payers and providers have attempted to rein in increasing drug costs, generic medications…
Expand
2006
2006
Use of orlistat (xenical) in the treatment of women with obesity and disorders of menstrual cycle
Totoian Es
,
F. Ng
,
Manasian As
,
Akopian Ma
,
Magevosian Aa
,
Arutiunian ZhS
2006
Corpus ID: 68059060
Obesity poses a serious threat for health, being a risk factor for development of heart diseases, diabetes type II, tumors, and…
Expand
2004
2004
[Complex assessment of metabolic parameters in obese patients treated with xenical].
A. Ametov
,
T. Demidova
,
A. L. Tselikovskaia
Терапевтический архив
2004
Corpus ID: 25971337
AIM To study effects of xenical combined with moderately hypocaloric diet on fat tissue mass, carbohydrate and lipid metabolism…
Expand
2002
2002
[Six-month xenical (orlistat) therapy of patients with stable angina pectoris concomitant with obesity and hyperlipidemia].
V. Naumov
,
V. Lupanov
,
I. V. Dotsenko
,
M. Tvorogova
Терапевтический архив
2002
Corpus ID: 37678724
AIM To evaluate the efficiency of 6-month therapy with xenical (gastrointestinal lipase inhibitor) in combination with diet in…
Expand
Review
1999
Review
1999
Orlistat (Xenical).
A. MacConnachie
Intensive & Critical Care Nursing
1999
Corpus ID: 21682828
The introduction of orlistat (Roche, UK) at the end of last year received considerable media coverage and was heralded in some…
Expand